Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 6,300 shares at $71.90 ($456K) on 2020-10-29, disclosed to the SEC on 2020-10-30.
Open-market sale of $456k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.90 | 1,300 | $93K | 20.5% |
| 2 | $71.90 | 1,300 | $93K | 20.5% |
| 3 | $72.60 | 3,700 | $269K | 59.0% |
| Total | $72.31 avg | 6,300 | $456K | 100% |
| Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |
| EIDX | SELL | 2019-09-27 | $96K | — | Filing → |